Masters recognises the importance of the role that Doctors play in creating access to potentially life-saving medicines, especially when the supply of a particular drug may not be available in some countries. By working with Masters, Doctors benefit from both its Global Reach and NPS experience, allowing them to prescribe unlicensed medicines from all over the wolrd, which may be:
- Awaiting registration
- Have been discontinued
- Are in a Clinical Trial
We understand that Doctors need appropriate support and information to be able to develop a comprehensive Named Patient Supply programme, which is why we offer such a personal service, providing support throughout the Named Patient Supply Programme.
Masters will also take care of various aspects of the program on behalf of the Doctors, including the following:
- Administration & Restrictions
- Treatment and Care Protocols to ensure proper selection of patients
Masters provides Doctors with key market intelligence and helps them build relations with key opinion leaders and other doctors who may be likely prescribers once a drug is registered. By participating in such programmes, doctors will not only gain valuable experience of a drug before registration, but may also be important resources for regulators and other local healthcare providers.
For more information on NPS programmes provided by Masters, simply refer to the following link:
Named patient supply (NPS)
- Named patient supply, also known as expanded access programmes (EAP), enables doctors to prescribe drugs that cannot be obtained through traditional prescribing channels.
- Click here to learn more about Masters' NPS programme.